PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32348960-0	2020	Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma.	Valsartan	11-20	gastrin	Homo sapiens	44-51	
32348960-11	2020	The results thus suggest that neprilysin-mediated degradation of gastrin and cholecystokinin is physiologically relevant and may have a role in heart failure patients treated with sacubitril/valsartan.	Valsartan	191-200	gastrin	Homo sapiens	65-72	
32348960-8	2020	Sacubitril/valsartan increased the postprandial plasma concentrations of both gastrin and cholecystokinin (80% (AUC0-270 min, P = 0.0038) and 60% (AUC0-270 min, P = 0.003), respectively) compared with the control meal.	Valsartan	11-20	gastrin	Homo sapiens	78-85	
32348960-10	2020	CONCLUSION: Our study demonstrates that sacubitril/valsartan increases the postprandial plasma concentrations of gastrin and cholecystokinin in healthy individuals.	Valsartan	51-60	gastrin	Homo sapiens	113-120